This is a preview of subscription content, log in via an institution to check access.
Notes
see Reactions 1677 p4; 803281800
Reference
European Medicines Agency. EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage. Internet Document : 10 Nov 2017. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/11/news_detail_002845.jsp&mid=WC0b01ac058004d5c1
Rights and permissions
About this article
Cite this article
EMA confirms restrictions for Zinbryta use. Reactions Weekly 1679, 1 (2017). https://doi.org/10.1007/s40278-017-38726-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-38726-y